Théo Ghelfenstein-Ferreira

Dr. Théo Ghelfenstein-Ferreira

Hôpital Saint-Louis, Paris, Île-de-France, France
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Medical Mycology Case Reports
Verified
Journal Article
Open access
TGThéo Ghelfenstein-Ferreira
Théo Ghelfenstein-Ferreira
ASAnastasia Saade
Anastasia Saade
Alexandre AlanioAlexandre Alanio
Alexandre Alanio
SBStéphane Bretagne
Stéphane Bretagne
RCRaffael Júnio Araújo de Castro
Raffael Júnio Araújo de Castro
SDSarah Dellière
Sarah Dellière
Although invasive pulmonary aspergillosis (IPA) is typically described in immunocompromised host, patient with severe influenzae can develop IPA. Similarly, patients with severe COVID-19 complicated with IPA are increasingly reported. Here, we describe a case of invasive aspergillosis with triazole-resistant A. fumigatus (TR34/L98H mutation) in a 56-year-old patient with COVID-19 in intensive care unit. This report highlights the need to define the available tools for diagnosis of invasive aspergillosis in severe COVID-19 patients.

4 July 2024 in Medical Mycology
Verified
Journal Article
Closed access
PDF file
ABAudrey Baron
Audrey Baron
SHSamia Hamane
Samia Hamane
MGMaud Gits-Muselli
Maud Gits-Muselli
LLLina Legendre
Lina Legendre
MBMazouz Benderdouche
Mazouz Benderdouche
SDSarah Dellière
Sarah Dellière
Trichophyton indotineae is an emerging species of the Trichophyton mentagrophytes complex (TMC), responsible for an epidemic of widespread hairless skin infections that is frequently (50-70%) resistant to terbinafine. In order to initiate appropriate treatment as quickly as possible without waiting for culture positivity (10-15 days) and molecular identification from the strain, we developed a dual quantitative PCR (qPCR) for the direct detection of T. indotineae in clinical samples. We first designed a T. indotineae specific qPCR assay (TI-qPCR) targeting a single specific polymorphism in the internal transcribed spacer region. Although none of the 94 non-dermatophyte and 7 dermatophyte species were amplified, this TI-qPCR allowed amplification of other TMC species at a lower yield. With equal amounts (0.1 ng) of DNA per reaction, the mean quantitative cycle (Cq) values for T. indotineae and non-indotineae TMC were 27.9 (±0.1) and 38.9 (±0.3), respectively. Therefore, we normalised this assay against a previously validated pan-dermatophyte qPCR assay (PD-qPCR) and relied on the ΔCq [(TI-qPCR) - (PD-qPCR)] to identify T. indotineae versus other TMC species. Dual assay was validated using 86 clinical samples of culture-confirmed T. indotinea and 19 non-indotineae TMC cases. The mean ΔCq for non-indotineae TMC was 9.6 ± 2.7, whereas the ΔCq for T. indotinea was -1.46 ± 2.1 (p < 0.001). Setting the ΔCq at 4.5 as a cut-off value resulted in 100% specificity for the detection of T. indotineae. This dual qPCR assay quickly detects T. indotineae from skin scrapings, aiding in early diagnosis and treatment for patients with suspected infection. Identifying the emerging species Trichophyton indotineae is long and requires to wait for culture positivity. We developed a dual qPCR strategy to detect T. indotineae directly from clinical sample with a 100% sensitivity.

27 July 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
TGThéo Ghelfenstein-Ferreira
Théo Ghelfenstein-Ferreira
LVLaura Verdurme
Laura Verdurme
Alexandre AlanioAlexandre Alanio
Alexandre Alanio
Standardized, reproducible and validated Mucorales quantitative PCR (qPCR) assays are needed in the context of routine testing in diagnostic labs. We, therefore, compared the commercial MucorGenius® assay (PathoNostics, Maastricht) targeting five genera of Mucorales to our in-house qPCR targeting Rhizomucor spp., Lichtheimia spp. and Mucor/Rhizopus spp. To assess their analytical sensitivity, 25 frozen leftover serum specimens, which had already tested positive based on our in-house assay, were selected. These sera were from 15 patients with probable or proven mucormycosis. For analytical specificity, 0.5 pg from 15 purified fungal DNAs from nine different Mucorales genera were spiked into pooled qPCR-negative leftover serum specimens. All samples were tested in parallel with both assays and the quantitative cycles (Cq) were compared. A total of 13/25 (52%) serum samples were amplified by one of the two assays with only four of them detected with the MucorGenius® assay. In spiked specimens, all targeted strains were successfully amplified by our in-house qPCR. The MucorGenius® assay was not able to detect Lichtheimia corymbifera but successfully amplified all other species targeted by the kit and two additional non-targeted species (Syncephalastrum monosporum and Saksenaea vasiformis). The MucorGenius® assay showed lower analytical sensitivity compared to our in-house assay. Indeed, the MucorGenius® assay amplified more species, as expected, but showed a decreased detection of the frequent species Lichtheimia corymbifera.

11 June 2025 in Journal of Clinical Microbiology
Verified
Journal Article
Open access
MDMarion Dutkiewicz
Marion Dutkiewicz
MGMaéva Garros
Maéva Garros
JBJulie Bui
Julie Bui
VCVéronique Charlier
Véronique Charlier
ESElodie Da Silva
Elodie Da Silva
Alexandre AlanioAlexandre Alanio
Alexandre Alanio
Identification of uncommon fungi using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF-MS) remains challenging. Its performance depends on the protein extraction method, instrument, algorithm, and database. This study compared two established mass spectrometers (VITEK MS [bioMérieux] and Microflex [Bruker]) to the new VITEK MS PRIME (bioMérieux) and four databases, including MSI-2, a non-commercial database constructed with spectra acquired with Bruker instruments. Isolates of Aspergillus species, rare molds, and uncommon yeasts, previously identified by sequencing, were analyzed. After a two-step protein extraction, MALDI-ToF-MS identification was performed, and spectra were submitted to in vitro diagnostic (IVD) (KB3.2 and KB3.3 [bioMérieux]), research use only (RUO) (FilFungi V5 [Bruker]) databases and MSI-2. A total of 169 isolates (61 Aspergillus spp., 72 rare molds, and 36 uncommon yeasts), representing 33 genera and 96 species, were included. Identification rates at species level for all fungi were similar between VITEK MS and VITEKMS PRIME (79% vs. 77%). The main difference lies in the rates of non-analyzable spectra, being 15% (26 strains) for VITEK MS PRIME versus only 3% (5 strains) for VITEK MS. For Aspergillus and rare molds, MSI-2 performed equally well on VITEK MS and Microflex (92% vs. 91%), indicating a spectra compatibility. For uncommon yeasts, all databases performed equally at the species level. For Aspergillus and rare molds, FilFungi V5 performed poorly (23% and 21%), while MSI-2 was best (77% and 82%) due to broader species coverage. Misidentifications mostly involved cryptic Aspergillus species. MALDI-ToF-MS is a powerful tool for identifying rare fungi. Improvements are needed in completing commercial databases and optimizing acquisition systems for fungal spectra. IMPORTANCE: Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-ToF-MS) is key for fungal identification nowadays. We present here the largest comparison of MALDI-ToF-MS instruments and databases focusing on rare yeasts and molds identification, challenging the existing instruments and both commercial and academic databases. The strains were collected in Saint Louis Hospital (Paris) and identified using bar-code sequencing. We showed that commercial databases are efficient for the identification of the main fungal species tested, whereas the academic database outperforms them for the identification of cryptic species.

10 September 2021 in Journal of Microbiology & Biology Education
Verified
Journal Article
Open access
TGThéo Ghelfenstein-Ferreira
Théo Ghelfenstein-Ferreira
ABAnne-Lise Beaumont
Anne-Lise Beaumont
SDSarah Dellière
Sarah Dellière
NPNathan Peiffer-Smadja
Nathan Peiffer-Smadja
NPNicolas Pineros
Nicolas Pineros
MLMathilde Lescat
Mathilde Lescat
Insufficient knowledge of bacteria and antimicrobials leads to the emergence of multidrug-resistant-bacterium infections. Diversification of the teaching forms, such as the use of games, could be a solution.

22 September 2020 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
TGThéo Ghelfenstein-Ferreira
Théo Ghelfenstein-Ferreira
MGMaud Gits-Muselli
Maud Gits-Muselli
SDSarah Dellière
Sarah Dellière
BDBlandine Denis
Blandine Denis
NGNicolas Guigue
Nicolas Guigue
SBStéphane Bretagne
Stéphane Bretagne
Amoebic liver abscess (ALA) is regularly seen in travelers or immigrants from tropical countries. The diagnosis relies on liver imaging that is not specific, and the detection of anti-Entamoeba histolytica antibodies, which cannot distinguish acute from former infection. We tested whether E. histolytica DNA detection in serum can improve the diagnosis of ALA. We retrospectively tested available serum samples from patients with ALA and non-ALA liver space-occupying lesions between 01/01/2010 and 11/30/2019. The quantitative PCR (qPCR) assay tested specifically amplifies a 99-bp fragment of the small-subunit rRNA gene of E. histolytica. We analyzed 76 samples (ALA=19; non-ALA=57) from 76 patients collected within 6 days before and after the anti-amoebic treatment. Serum qPCR was positive in 17 of 19 ALA patients and in none of the control patients (sensitivity and specificity were 89.5% and 100%, respectively). In parallel, the sensitivity and specificity of the anti-E. histolytica antibody detection were 100% and 89.5%, respectively. The two false-negative qPCR results may be explained by ongoing metronidazole treatment or a possible persistent seropositivity that is not caused by the current liver abscess. Additionally, out of 12 abscess pus aspirates (ALA=5; non-ALA=7) tested, 5 were qPCR positive and 7 were qPCR negative with concordant results on serum. This study demonstrates that cell-free circulating E. histolytica DNA can be detected in serum in ALA. This may assist in both positive diagnoses and treatment efficacy follow-up. The origin of this circulating DNA remains to be investigated.